Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...
Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...
A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that ...
Scripps News on MSN6d
British drugmaker sues Moderna for patent infringement related to mRNA vaccinesA British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...
(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of ...
GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax ...
GlobalData on MSN4d
mRNA licensing agreements surge 800% amid GSK lawsuitsAn 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...
A new trial that aims to protect against norovirus, a highly contagious stomach bug that causes vomiting and diarrhoea, is ...
Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback